Found: 90
Select item for more details and to access through your institution.
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Microendoscopic calcium imaging of the primary visual cortex of behaving macaques.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96532-z
- By:
- Publication type:
- Article
Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 2, p. 223, doi. 10.1093/jjco/hyz208
- By:
- Publication type:
- Article
Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1083, doi. 10.1093/jjco/hyz135
- By:
- Publication type:
- Article
dose-finding randomized Phase II study of oral netupitant in combination with palonosetron.75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 121, doi. 10.1093/jjco/hyy161
- By:
- Publication type:
- Article
Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 983, doi. 10.1093/jjco/hyv110
- By:
- Publication type:
- Article
Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 1, p. 33, doi. 10.1007/s10549-024-07333-7
- By:
- Publication type:
- Article
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 135, doi. 10.1007/s10549-020-05524-6
- By:
- Publication type:
- Article
β<sub>2</sub>-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 3, p. 603, doi. 10.1007/s10549-019-05341-6
- By:
- Publication type:
- Article
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 675, doi. 10.1007/s10549-018-4873-0
- By:
- Publication type:
- Article
Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1540, doi. 10.1007/s10637-019-00890-5
- By:
- Publication type:
- Article
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 140, doi. 10.1007/s10637-019-00829-w
- By:
- Publication type:
- Article
Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 538, doi. 10.1007/s10637-019-00755-x
- By:
- Publication type:
- Article
A possible aid in targeted insertion of large DNA elements by CRISPR/Cas in mouse zygotes.
- Published in:
- Genesis: The Journal of Genetics & Development, 2016, v. 54, n. 2, p. 65, doi. 10.1002/dvg.22914
- By:
- Publication type:
- Article
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 262, doi. 10.1007/s10147-018-1359-3
- By:
- Publication type:
- Article
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 6, p. 1102, doi. 10.1007/s10147-015-0832-5
- By:
- Publication type:
- Article
Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401).
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 6, p. 982, doi. 10.1007/s10147-013-0657-z
- By:
- Publication type:
- Article
A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 4, p. 590, doi. 10.1007/s10147-012-0421-9
- By:
- Publication type:
- Article
Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 3, p. 547, doi. 10.1007/s10147-012-0418-4
- By:
- Publication type:
- Article
Thalamocortical control of cell-type specificity drives circuits for processing whisker-related information in mouse barrel cortex.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41749-x
- By:
- Publication type:
- Article
Effects of Nattokinase on Blood Pressure: A Randomized, Controlled Trial.
- Published in:
- Hypertension Research, 2008, v. 31, n. 8, p. 1583, doi. 10.1291/hypres.31.1583
- By:
- Publication type:
- Article
Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4008, doi. 10.3390/cancers13164008
- By:
- Publication type:
- Article
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 1, p. 99, doi. 10.1007/s10549-016-3856-2
- By:
- Publication type:
- Article
Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 2, p. 295, doi. 10.1007/s10549-016-3808-x
- By:
- Publication type:
- Article
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 2, p. 401, doi. 10.1007/s10549-014-2947-1
- By:
- Publication type:
- Article
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 127, doi. 10.1007/s10549-009-0498-7
- By:
- Publication type:
- Article
Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 107, n. 1, p. 87
- By:
- Publication type:
- Article
Pembrolizumab plus chemotherapy in Japanese patients with triple‐negative breast cancer: Results from KEYNOTE‐355.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10280, doi. 10.1002/cam4.5757
- By:
- Publication type:
- Article
Palbociclib‐letrozole as first‐line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4929, doi. 10.1002/cam4.3091
- By:
- Publication type:
- Article
Clinicopathological values of PD-L1 expression in HER2-positive breast cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52944-6
- By:
- Publication type:
- Article
A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1507, doi. 10.1007/s00520-011-1239-0
- By:
- Publication type:
- Article
A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 10, p. 970, doi. 10.1093/jjco/hys120
- By:
- Publication type:
- Article
Multicenter Phase II Trial of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
- Published in:
- Japanese Journal of Clinical Oncology, 2003, v. 33, n. 8, p. 371, doi. 10.1093/jjco/hyg075
- By:
- Publication type:
- Article
Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 603, doi. 10.1007/s00280-014-2545-2
- By:
- Publication type:
- Article
Deficiency of CHAMP1, a gene related to intellectual disability, causes impaired neuronal development and a mild behavioural phenotype.
- Published in:
- Brain Communications, 2022, v. 4, n. 5, p. 1, doi. 10.1093/braincomms/fcac220
- By:
- Publication type:
- Article
Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93620-y
- By:
- Publication type:
- Article
Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study.
- Published in:
- Patient Related Outcome Measures, 2020, v. 11, p. 67, doi. 10.2147/PROM.S238009
- By:
- Publication type:
- Article
Morphological Study of the Accommodative Apparatus in the Monkey Eye.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2015, v. 298, n. 3, p. 630, doi. 10.1002/ar.23100
- By:
- Publication type:
- Article
Developmental Anatomy in the Zonular Connection with Lens Capsule in Macaque Eye.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2013, v. 296, n. 5, p. 726, doi. 10.1002/ar.22684
- By:
- Publication type:
- Article
Developmental Anatomy in the Zonular Connection with Lens Capsule in Macaque Eye.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2013, v. 296, n. 5, p. C1, doi. 10.1002/ar.22561
- By:
- Publication type:
- Article
Localization of Papillofoveal Bundles in Primates.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2012, v. 295, n. 2, p. 347, doi. 10.1002/ar.21519
- By:
- Publication type:
- Article
BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 5, p. 405, doi. 10.1002/gcc.22445
- By:
- Publication type:
- Article
Quality of life and its associations with illness perceptions over a 3-month follow-up period in patients with non-small cell lung cancer: A prospective longitudinal study.
- Published in:
- World Academy of Sciences Journal, 2021, p. 1, doi. 10.3892/wasj.2021.126
- By:
- Publication type:
- Article
True Recurrences and New Primary Tumors Have Different Clinical Features in Invasive Breast Cancer Patients with Ipsilateral Breast Tumor Relapse After Breast-Conserving Treatment.
- Published in:
- Breast Journal, 2010, v. 16, n. 2, p. 127, doi. 10.1111/j.1524-4741.2009.00884.x
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy Alone Has No Adverse Impact on the Survival of Patients with Breast Cancer.
- Published in:
- Breast Journal, 2006, v. 12, p. S157, doi. 10.1111/j.1075-122X.2006.00329.x
- By:
- Publication type:
- Article